Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 31, 2005 Stephen D. Simpson	Kinetic Takes a Flesh Wound Although a recent reimbursement decision was unexpected for this wound care specialist, the stock market seems to have overreacted. Investors, take note.
The Motley Fool July 31, 2006 Stephen D. Simpson	Kinetic Concepts Approaches a Binary Outcome The resolution of a patent infringement trial means far more than one quarter's results for this med-tech company. Investors, take note.
The Motley Fool April 25, 2006 Stephen D. Simpson	Kinetic Energy Although Kinetic Concepts' key patent trial has yet to begin, the stock of this wound-care specialist has been lurching up as investors apparently get a little more comfortable with the risk-reward tradeoff.
The Motley Fool August 4, 2006 Stephen D. Simpson	Ruling Slows Down Kinetic Concepts Losing a key patent case will become a severe blow for this med-tech company if it isn't overturned on appeal. Investors, beware.
The Motley Fool January 27, 2009 Brian Orelli	Not All Medical Device Makers Are Hurting While slowdowns in capital spending at hospitals wreaked havoc on other medical-device makers Kinetic Concepts seems to have been able to get through it with only minor bruises.
The Motley Fool April 22, 2009 Brian Orelli	You Left Out the Kitchen Sink, KC There was something for nearly everyone in this quarter's earnings release from Kinetic Concepts. The company's three segments ran the gamut of what's possible in this economy.
IndustryWeek December 16, 2009	IW50 Profile: Kinetic Concepts -- How Kinetic Concepts Stays Healthy Medical products manufacturer has a strategy for thriving during tough economic times.
The Motley Fool July 21, 2011	Kinetic Concepts Earnings Preview Kinetic Concepts, a global medical technology company, will unveil its latest earnings on Tuesday, July 26.
The Motley Fool April 8, 2008 Brian Orelli	Kinetic Concepts Grafts On a New Division Wound-management products company Kinetic Concepts buys tissue-repair product manufacturer LifeCell for a premium.
The Motley Fool June 14, 2010 Todd Wenning	One of the Riskiest Investments You Can Make You can make money buying shares of well-run companies; there just needs to be another factor the market is missing, in order for you to buy them at the right price.
The Motley Fool May 27, 2010 Rich Smith	This Just In: Upgrades and Downgrades Brigantine recommends purchase of Kinetic Concepts in the medical products arena.
BusinessWeek September 12, 2005 Mara Der Hovanesian	Healing Ahead For Kinetic Concepts Kinetic Concepts, which markets wound-healing and tissue-repair devices, now trades at 55.
BusinessWeek October 31, 2005 Spencer E. Ante	Crashing The Stent Party Conor Medsystems is trying to take on Goliaths J&J and Boston Scientific.
The Motley Fool July 1, 2011 Luke Timmerman	Dendreon Sways Medicare to Pay for Prostate Cancer Drug The decision by Medicare is no surprise, but it does conclude a period of uncertainty about insurance reimbursement for its lone marketed product.
Information Today April 4, 2011	LexisNexis Announces New IP Research Technology With Semantic Search "Brain" The next-generation semantic search technology identifies the meaning of multiple concepts within a single search query to help users zero in on core concepts faster and make fewer revisions to their search queries.
Pharmaceutical Executive December 1, 2011 Lujing Wang	The Payoff for Payers Thorough risk assessment is essential before placing bets on good evidence that clears a path to approval.
Chemistry World July 10, 2013 Darren Smyth	How to invent and protect your invention Even as an account of US patent law, this book, by Kennedy et al., has little to commend it. It is difficult to understand in many places, the selection of topics for coverage is peculiar, and is downright wrong in many details.
Information Today August 3, 2009	Thomson Reuters Introduces New IP Offering for Law Firms This new offering pairs the authoritative legal content of Westlaw with the rich patent research capabilities of Thomson Innovation. It is designed to help legal professionals work smarter and more efficiently across the patent workflow-from patent prosecution to litigation.
Information Today December 10, 2012	Thomson Reuters Announces Cortellis for Clinical Trials Intelligence Scheduled for release in early 2013, this capability will provide drug development and clinical professionals with the critical information.
InternetNews March 9, 2011	Senate Approves Sweeping Patent Overhaul Bill By an overwhelming margin, upper chamber clears landmark patent reform bill years in the making, aimed at curbing litigation and improving efficiency at the U.S. PTO.
The Motley Fool September 1, 2010 Brian Orelli	Dendreon: One Step Closer to Worry-Free Back in July, the Centers for Medicare & Medicaid Services announced that it planned on reviewing the reimbursement for Dendreon's prostate cancer treatment Provenge.
The Motley Fool February 24, 2004 Rick Aristotle Munarriz	A Little Kinetic Energy Kinetic goes public in an energetic market, but should you be in a hurry to buy in?
Bio-IT World October 2006 Mark D. Uehling	Datasci Suits Threaten Industry The U.S. Patent Office is under scrutiny in a series of lawsuits that are baffling the world of clinical trial technology.
Information Today July 6, 2010 George H. Pike	Supreme Court Confirms Patentability of Business Methods, Denies Bilski Patent The lengthy and complex decision, entitled Bilski v. Kappos, affirmed the legality of business method patents, while leaving unanswered some questions about the scope and breadth of such patents.
The Motley Fool July 29, 2008 Dan Dzombak	3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: AuthenTec... Cresud... Kinetic Concepts...
The Motley Fool May 5, 2005 Stephen D. Simpson	Will Anybody Love Angiotech? Despite the success of the Boston Scientific Taxus stent, Angiotech's stock is trading at low levels.
The Motley Fool September 17, 2011	What's Fueling the Tech Patent Bull Market? As companies amass patents to sue each other, is it time for the patent system to be reformed?
CIO January 1, 2003 Christopher Koch	Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled.
Chemistry World September 14, 2007 Peter Mitchell	European Patents Set to Get Cheaper Patents valid across many European countries will soon be much easier and cheaper to register, with the coming into force of the so-called London Agreement.
The Motley Fool February 2, 2011 Bryan Hinmon	Are Home Health Stocks Too Cheap? Home health agency stocks are cheap -- is now a time to buy?
IndustryWeek August 1, 2006	Patents: Eleven Issues To Consider... How patent savvy are you?
The Motley Fool June 15, 2010 Todd Wenning	3 Out-of-Favor Investments to Buy Today Understanding the market's ebb and flow is the key to success.
The Motley Fool January 31, 2008 Dave Mock	Have Patent, Will Sue As reforms and regulation slowly trickle in, the telecom industry is still subject to patent abuse.
The Motley Fool May 17, 2006 Stephen D. Simpson	Angiotech Pharmaceuticals: Rebuilding or Reloading? This small Canadian drug-delivery outfit is reshaping and diversifying. Investors, is it time to buy?
Chemistry World April 2012 Darren Smyth	Be Careful What You Wish for The struggle for a single unitary European patent may be close to an end, but we must still hold out for an agreement that performs as it should.
InternetNews March 5, 2007 Roy Mark	The 'Wikifying' of Software Patents Utilizing social networking tools, a Patent and Trademark Office pilot program aims to speed applications and better inform patent examiners.
IEEE Spectrum February 2006 Lee A. Hollaar	Patents 2.0 There are big problems with patents, especially software patents. A new type of patent is needed -- Congress should create a new, limited protection that protects against knockoffs without overreaching.
The Motley Fool November 28, 2008 Brian Orelli	Bargain Stocks for Black Friday: Intuitive Surgical This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, its 25 P/E is pretty darn cheap.
Information Today March 24, 2003 Nancy Lambert	Thomson Opens Its Patent Store This service plans to provide a truly comprehensive patent document delivery service, with one-stop shopping for virtually all patents from any time period, anywhere in the world, and to provide it via high-speed Web access.
The Motley Fool May 27, 2011 Alyce Lomax	Making Sure Shareholders Matter The days of "like it or sell it" are over.
The Motley Fool August 1, 2008 Dan Dzombak	3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: Cemex... Aluminum Corp. of China... Kinetic Concepts...
IEEE Spectrum March 2007 Steven Rubin	Hooray for the Patent Troll! Patent owners who are often accused of being patent trolls are acting within the law. There is nothing wrong either with them or the law. Far from stifling innovation, trolls foster it. By creating market liquidity, "patent trolls" provide a valuable service to inventors.
InternetNews February 16, 2007 Roy Mark	Patent Reform: Beware of Unintended Consequences Is it fair to patent software?
InternetNews March 28, 2011	Kodak CEO Hopes for $1 Billion in Patent Suit Eastman Kodak's head told Bloomberg he thinks a patent victory in court could bring in $1 billion. Kodak sued Apple and RIM in January 2010 for what it claims is infringement of a patent it holds in the area of previewing images in iPhone and Blackberry mobile devices.
InternetNews March 10, 2005 Susan Kuchinskas	Mr. Smith Went to Washington For Patent Reform Microsoft General Counsel Brad Smith calls for patent reform at the American Enterprise Institute.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
Bank Systems & Technology May 24, 2007 Maria Bruno-Britz	Banks Need Patents, Experts Say In light of recent patent litigation, banks must understand the importance of protecting their innovations.
The Motley Fool April 26, 2005 Dave Mock	The Lowdown on Patent Shakedowns The business of extorting license fees for patents can be very lucrative -- and damaging. It is important for investors to understand how the companies they own utilize and protect their inventions -- and what approach management has taken to deal with intellectual property disputes.
IEEE Spectrum November 2008 Kirk Teska	Commentary: Business-Method Patents--Down But Not Out? The Bilski case leaves us with more questions than answers
The Motley Fool March 25, 2011 Travis Hoium	Schweitzer-Mauduit International Shares Plunged: What You Need to Know Shares of Schweitzer-Mauduit fell 10% today when the company announced one of its patents had been "rejected."